Introduction
The legalization of medical cannabis in Canada, beginning in 2001 and culminating with the full legalization of both medical and recreational cannabis in 2018, has placed the country at the forefront of global cannabis policy. While the move was celebrated as a significant step towards a more compassionate and scientifically informed approach to healthcare, it has also introduced a complex and evolving legal and regulatory landscape. The intersection of medicine, law, and policy surrounding medical cannabis presents a variety of challenges—both for patients who seek access to it and for healthcare providers who must navigate its use. Despite the progress made in legalizing medical cannabis, the regulatory framework remains far from straightforward, and a number of legal and logistical hurdles persist.
This article examines the legal and regulatory challenges of medical cannabis in Canada, focusing on the regulatory framework established under the Cannabis Act, the role of Health Canada in overseeing medical cannabis use, issues surrounding prescription and distribution, and legal gray areas that complicate patient access and public understanding. In addition, it considers how these challenges affect both patients and healthcare providers, and why there is a pressing need for clearer and more comprehensive regulatory policies.
Regulatory Framework
The Cannabis Act, which came into force in October 2018, represents the legal backbone of Canada’s cannabis policy. This law legalizes the production, distribution, sale, and possession of cannabis for both medical and recreational use. For medical cannabis, the law provides specific provisions aimed at protecting patients while also ensuring that cannabis is used safely and responsibly.